Open AccessNotoginsenoside R1 attenuates breast cancer progression by targeting CCND2 and YBX3
Author(s) -
Hailong Qin,
Xuejun Wang,
Bi-Xian Yang,
Bin Du,
Xue-Lin Yun
Publication year - 2021
Publication title -
chinese medical journal/chinese medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.537
H-Index - 63
eISSN - 2542-5641
pISSN - 0366-6999
DOI - 10.1097/cm9.0000000000001328
Subject(s) - pi3k/akt/mtor pathway , protein kinase b , cell cycle , apoptosis , cancer research , wortmannin , oncogene , panax notoginseng , cell growth , breast cancer , cancer , kinase , biology , medicine , chemistry , pathology , microbiology and biotechnology , biochemistry , alternative medicine